Executive/Senior CRO and pharmaceutical professional with 20+ years of executive industry performance and thought leadership in the building of innovative service lines within the traditional and decentralized clinical trial arena resulting in increased patient centricity and timely delivery of clinical programs. Known for vision, strategy, planning, and elite execution of end-to-end clinical program portfolios. Recognized for keen insight and analysis, quality and scientific rigor, business acumen, attention to detail, and sound decision making. Emphasizes relationships and collaboration with stakeholders, KOLs, patient advocacy groups, vendors. Grasps and synthesizes complexity and articulates clear solutions. Bring highly refined communication and presentation skills. Passionate about ownership, accountability, and results orientation. A nimble, empathic leader with uncompromised performance standards. Unceasing curiosity – always learning.Core Competencies• Clinical program portfolio strategy and execution• 9+ years of Decentralized Trial Strategy Development• Strategic, operational, and growth leadership• Development plans and commercialization• Complex clinical development issues • P&L, budgets, forecasts, revenue generation• Developing service lines with integration into company services and processes. • Regulatory strategy and compliance • Complex concurrent project management• Systems, processes, SOPs, and management tools• Clinical program quality and content• Scientifically rigorous/cost effective protocol design• Clinical trials – phase I to IV• Change management• Cross-functional alignment and collaboration• Elite team building and culture development